ASPN

Aspen Aerogels, Inc. [ASPN] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ASPN Stock Summary

Top 10 Correlated ETFs

ASPN


Top 10 Correlated Stocks

ASPN


In the News

04:15 29 Sep 2023 ASPN

Aspen Aerogels to Participate in September Investor Conferences

NORTHBOROUGH, Mass. , Aug. 29, 2023 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today announced that the Company is scheduled to participate in the following investor events in September: (i) Barclays CEO Energy-Power Conference and (ii) the Piper Sandler Battery Summit.

11:49 29 Sep 2023 ASPN

Aspen Aerogels, Inc. (ASPN) Q2 2023 Earnings Call Transcript

Aspen Aerogels, Inc. (NYSE:ASPN ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Neal Baranosky - Senior Director of Corporate of Strategy & Finance Donald Young - President & Chief Executive Officer Ricardo Rodriguez - Chief Financial Officer Conference Call Participants Eric Stine - Craig-Hallum Alex Potter - Piper Sandler Jeffrey Osborne - TD Cowen George Gianarikas - Canaccord Genuity Christopher Souther - B. Riley Thomas Curran - Seaport Amit Dayal - H.C.

08:13 29 Sep 2023 ASPN

Aspen Aerogels (ASPN) Reports Q2 Loss, Lags Revenue Estimates

Aspen Aerogels (ASPN) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.68 per share a year ago.

06:30 29 Sep 2023 ASPN

Aspen Aerogels, Inc. Schedules Second Quarter Earnings Release and Conference Call

NORTHBOROUGH, Mass. , July 20, 2023 /PRNewswire/ -- Aspen Aerogels, Inc. (the "Company") (NYSE: ASPN) today announced that Don Young, President & Chief Executive Officer, and Ricardo C.

06:12 29 Sep 2023 ASPN

Aspen Aerogels: Not Insulating Investors From The Cold

Aspen Aerogels was an intriguing business when it went public nearly a decade ago. Shares have been suffering ever since, except for a momentum run, and subsequent bust in the years which followed. I am cautious amidst the continued losses and investments, making me quite cautious here.

04:15 29 Sep 2023 ASPN

Aspen Aerogels to Present at TD Cowen Sustainability Week

NORTHBOROUGH, Mass. , May 25, 2023 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today announced that the Company is scheduled to present at the TD Cowen Sustainability Week on Tuesday, June 6, 2023.

03:07 29 Sep 2023 ASPN

Aspen Aerogels, Inc. (ASPN) Q1 2023 Earnings Call Transcript

Aspen Aerogels, Inc. (NYSE:ASPN ) Q1 2023 Earnings Conference Call May 4, 2023 8:30 AM ET Company Participants Neal Baranosky - Senior Director, Corporate of Strategy & Finance Donald Young - President & CEO Ricardo Rodriguez - CFO Conference Call Participants Eric Stine - Craig-Hallum Ben Johnson - Piper Sandler Colin Rusch - Oppenheimer Jeffrey Osborne - Cowen George Gianarikas - Canaccord Genuity Christopher Souther - B. Riley Operator Good morning.

08:32 29 Sep 2023 ASPN

Aspen Aerogels (ASPN) Reports Q1 Loss, Tops Revenue Estimates

Aspen Aerogels (ASPN) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.59 per share a year ago.

06:30 29 Sep 2023 ASPN

Aspen Aerogels, Inc. Schedules First Quarter Earnings Release and Conference Call

NORTHBOROUGH, Mass. , April 20, 2023 /PRNewswire/ -- Aspen Aerogels, Inc. (the "Company") (NYSE: ASPN) today announced that Don Young, President & Chief Executive Officer, and Ricardo C.

04:06 29 Sep 2023 ASPN

Aspen Aerogels, Inc. (ASPN) Q4 2022 Earnings Call Transcript

Aspen Aerogels, Inc. (NYSE:ASPN ) Q4 2022 Earnings Conference Call February 16, 2023 8:30 AM ET Company Participants Laura Guerrant - VP, IR and Corporate Communications Don Young - President and CEO Ricardo Rodriguez - CFO Conference Call Participants Eric Stine - Craig-Hallum Colin Rusch - Oppenheimer Chris Souther - B. Riley Alex Potter - Piper Sandler George Gianarikas - Canaccord Genuity Jeff Osborne - Cowen Amit Dayal - H.C.

ASPN Financial details

Company Rating
Buy
Market Cap
470.39M
Income
-70.82M
Revenue
190.06M
Book val./share
6.06
Cash/share
1.94
Dividend
-
Dividend %
-
Employees
533
Optionable
No
Shortable
Yes
Earnings
24 Oct 2023
P/E
-8.31
Forward P/E
-
PEG
-1.56
P/S
3.14
P/B
1.4
P/C
4.28
P/FCF
-1.78
Quick Ratio
2.72
Current Ratio
3.47
Debt / Equity
0.32
LT Debt / Equity
0.31
-
-
EPS (TTM)
-1.41
EPS next Y
-
EPS next Q
-0.18
EPS this Y
138.04%
EPS next Y
-
EPS next 5Y
0.71%
EPS last 5Y
8.6%
Revenue last 5Y
11.56%
Revenue Q/Q
5.64%
EPS Q/Q
-
-
-
-
-
SMA20
16.67%
SMA50
-12.5%
SMA100
-
Inst Own
95.84%
Inst Trans
0.99%
ROA
-11%
ROE
-19%
ROC
-0.13%
Gross Margin
11%
Oper. Margin
-39%
Profit Margin
-37%
Payout
-
Shs Outstand
70.21M
Shs Float
68.32M
-
-
-
-
Target Price
27.33
52W Range
5.325-14.44
52W High
-40.64%
52W Low
+66.2%
RSI
72
Rel Volume
2.89
Avg Volume
724.18K
Volume
2.09M
Perf Week
28.44%
Perf Month
40.61%
Perf Quarter
28.24%
Perf Half Y
15.26%
-
-
-
-
Beta
2.17151
-
-
Volatility
0.85%, 0.77%
Prev Close
-2.23%
Price
8.3102
Change
11.25%

ASPN Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
4.45.783.844.58
Net income per share
-1.45-0.2-0.45-0.92-2.19
Operating cash flow per share
-0.36-0.04-0.38-0.61-2.4
Free cash flow per share
-0.52-0.13-0.51-1.06-6.92
Cash per share
0.140.150.632.527.15
Book value per share
2.962.452.574.2211.37
Tangible book value per share
2.962.452.574.2211.26
Share holders equity per share
2.962.452.574.2211.37
Interest debt per share
0.20.370.320.513.35
Market cap
50.56M187.01M440.24M1.52B464.09M
Enterprise value
51.42M191.83M432.06M1.45B309.41M
P/E ratio
-1.47-39.3-37.15-54.34-5.38
Price to sales ratio
0.481.344.3912.462.57
POCF ratio
-5.84-177.43-44.36-81.34-4.92
PFCF ratio
-4.13-59.07-33-46.76-1.7
P/B Ratio
0.723.176.4911.81.04
PTB ratio
0.723.176.4911.81.04
EV to sales
0.491.384.3111.951.72
Enterprise value over EBITDA
-1.94-13.55-20.03-35.81-3.99
EV to operating cash flow
-5.94-182-43.54-78.05-3.28
EV to free cash flow
-4.2-60.59-32.39-44.87-1.14
Earnings yield
-0.68-0.03-0.03-0.02-0.19
Free cash flow yield
-0.24-0.02-0.03-0.02-0.59
Debt to equity
0.060.140.120.120.28
Debt to assets
0.040.080.090.080.2
Net debt to EBITDA
-0.03-0.340.381.511.99
Current ratio
1.611.53.383.074.66
Interest coverage
-64.73-34.87-89.87-177.29-15.51
Income quality
0.250.070.460.51.14
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.180.120.160.190.21
Research and developement to revenue
0.060.060.090.090.09
Intangibles to total assets
00000
Capex to operating cash flow
0.4220.340.741.89
Capex to revenue
-0.03-0.02-0.03-0.11-0.99
Capex to depreciation
-0.33-0.21-0.33-1.46-19.3
Stock based compensation to revenue
0.040.030.050.040.05
Graham number
9.833.35.19.3323.67
ROIC
-0.32-0.06-0.15-0.19-0.14
Return on tangible assets
-0.35-0.05-0.12-0.15-0.13
Graham Net
-0.11-0.510.21.423.36
Working capital
14.19M15.34M33.2M75.6M290.36M
Tangible asset value
70.25M58.99M67.85M128.41M443.34M
Net current asset value
8.48M1.26M17.55M57.6M166.45M
Invested capital
0.060.140.120.120.28
Average receivables
26.16M28.91M23.98M18.06M38.89M
Average payables
11.52M12.49M8.97M11.4M36.08M
Average inventory
8.12M8.04M10.93M12.54M17.26M
Days sales outstanding
89.4184.4757.1461.3116.06
Days payables outstanding
49.3340.6522.857113.89
Days of inventory on hand
29.1328.355.839.1746.9
Receivables turnover
4.084.326.395.953.14
Payables turnover
7.48.9816.016.43.2
Inventory turnover
12.5312.96.549.327.78
ROE
-0.49-0.08-0.17-0.22-0.19
Capex per share
-0.15-0.09-0.13-0.45-4.52

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
Revenue per share
1.30.931.210.660.7
Net income per share
-0.72-0.78-0.19-0.22-0.22
Operating cash flow per share
-0.29-0.95-0.49-0.36-0.11
Free cash flow per share
-1.36-2.64-1.68-1.07-1.06
Cash per share
4.612.595.7231.94
Book value per share
4.684.619.096.256.06
Tangible book value per share
4.684.619.016.256.06
Share holders equity per share
4.684.619.096.256.06
Interest debt per share
3.523.22.591.761.93
Market cap
347.85M364.5M580.08M515.26M546.38M
Enterprise value
308.13M386.69M425.4M429.35M545.81M
P/E ratio
-3.42-2.95-15.18-8.61-8.86
Price to sales ratio
7.629.939.7311.311.35
POCF ratio
-34.66-9.73-24.09-20.9-71.14
PFCF ratio
-7.26-3.49-7.01-6.96-7.41
P/B Ratio
2.1121.31.191.3
PTB ratio
2.1121.31.191.3
EV to sales
6.7510.537.149.4211.33
Enterprise value over EBITDA
-13.69-13.88-49.45-25.99-35.88
EV to operating cash flow
-30.71-10.32-17.67-17.42-71.07
EV to free cash flow
-6.43-3.7-5.14-5.8-7.41
Earnings yield
-0.07-0.08-0.02-0.03-0.03
Free cash flow yield
-0.14-0.29-0.14-0.14-0.13
Debt to equity
0.740.680.280.280.32
Debt to assets
0.340.320.20.20.22
Net debt to EBITDA
1.77-0.817.985.20.04
Current ratio
31.934.664.33.47
Interest coverage
-14.61-16.33-9.6-68.76-80.78
Income quality
0.421.272.511.470.5
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.20.270.20.270.28
Research and developement to revenue
0.10.130.070.090.08
Intangibles to total assets
00000
Capex to operating cash flow
3.771.792.4328.6
Capex to revenue
-0.83-1.83-0.98-1.08-1.37
Capex to depreciation
-18.62-26.47-23.17-18.26-18.84
Stock based compensation to revenue
0.050.070.040.050.06
Graham number
8.729.016.35.525.51
ROIC
-0.08-0.09-0.02-0.03-0.03
Return on tangible assets
-0.07-0.08-0.01-0.02-0.02
Graham Net
0.05-1.772.690.99-0.19
Working capital
142.08M75.32M290.36M227.21M162.41M
Tangible asset value
164.75M182.41M443.34M432.54M419.97M
Net current asset value
22.1M-46.73M166.45M107.85M30.93M
Invested capital
0.740.680.280.280.32
Average receivables
27.01M28.3M42.23M52.32M45.72M
Average payables
40.6M54.72M56.53M53.78M50.44M
Average inventory
16.25M18.8M21.57M24.77M30.15M
Days sales outstanding
58.1466.4986.5993.3482.54
Days payables outstanding
98.21121.89108.79117.38108.82
Days of inventory on hand
32.6643.0544.860.0275.37
Receivables turnover
1.551.351.040.961.09
Payables turnover
0.920.740.830.770.83
Inventory turnover
2.762.092.011.51.19
ROE
-0.15-0.17-0.02-0.03-0.04
Capex per share
-1.08-1.69-1.19-0.71-0.95

ASPN Frequently Asked Questions

What is Aspen Aerogels, Inc. stock symbol ?

Aspen Aerogels, Inc. is a US stock , located in Northborough of Ma and trading under the symbol ASPN

Is Aspen Aerogels, Inc. buy or a sell ?

4 stock analysts have 4 predictions with a medium analyst target price of $32.5. The lowest prediction is $18 and the highest is $48

What is ASPN stock prediction ?

What is Aspen Aerogels, Inc. stock quote today ?

Aspen Aerogels, Inc. stock price is $8.3102 today.

Is Aspen Aerogels, Inc. stock public?

Yes, Aspen Aerogels, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap